Marc Grasso

Marc Grasso

No open positions remaining

Net worth: 639 516 $ as of 30/05/2026

53 year
Finance
Health Technology
Consumer Services

Profile

Marc Edward Grasso formerly worked at Morgan Stanley & Co. LLC, as Executive Director-Investment Banking, Leerink Partners LLC, as Managing Director from 2008 to 2010, Leerink Swann & Co., as Managing Director-Investment Banking from 2008 to 2010, Credit Suisse Securities (USA) LLC (Broker), as Vice President-Investment Banking, Stifel Financial Corp., as MD-Healthcare Investment Banking Group from 2013 to 2018, UBS Group AG, as MD-Investment Banking & Global Healthcare Group from 2010 to 2013, Kura Oncology, Inc., as Secretary, Chief Financial & Business Officer in 2019, Kyverna Therapeutics, Inc., as Chief Financial Officer & Accounting Officer from 2025 to 2026, and Alector, Inc., as Chief Financial Officer from 2022 to 2025.
Dr. Grasso received his undergraduate degree from Princeton University and doctorate degree from The Johns Hopkins University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/06/2025 296,072 ( 0.27% ) 639 516 $ 30/05/2026

Former positions of Marc Grasso

CompaniesPositionEnd
KYVERNA THERAPEUTICS, INC. Director of Finance/CFO 17/05/2026
ALECTOR, INC. Director of Finance/CFO 19/06/2025
KURA ONCOLOGY, INC. Director of Finance/CFO 03/02/2022
STIFEL FINANCIAL CORP. Corporate Officer/Principal 30/06/2018
UBS GROUP AG Corporate Officer/Principal 31/01/2013
See the detail of Marc Grasso's experience

Training of Marc Grasso

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Finance

Finance

Health Technology

Finance

Finance

Consumer Services

Health Technology

Consumer Services

Finance

Health Technology